EVH – evolent health, inc class a (US:NASDAQ)
Stock Stats
News
12/2
03:00 pm
evh
Low
Evolent Health (NYSE:EVH) was given a new $6.00 price target on by analysts at Piper Sandler.
11/26
02:06 pm
evh
Low
Evolent Health (NYSE:EVH) had its "sell (e+)" rating reaffirmed by analysts at Weiss Ratings.
11/21
03:23 pm
evh
Low
Evolent Health (NYSE:EVH) had its price target lowered by analysts at Citigroup Inc. from $11.50 to $9.50. They now have a "buy" rating on the stock.
11/20
01:47 am
evh
Low
Evolent Health, American Oncology Network Partner to Streamline Cancer Care [Yahoo! Finance]
11/17
12:37 pm
evh
Medium
Evolent Health (NYSE:EVH) had its price target lowered by analysts at JPMorgan Chase & Co. from $13.00 to $7.00. They now have an "overweight" rating on the stock.
11/6/2025
04:10 pm
EVH
-19.1%
BEAT
8/7/2025
04:10 pm
EVH
-4.3%
MISS
5/8/2025
04:10 pm
EVH
-16.0%
BEAT
2/20/2025
04:10 pm
EVH
-2.6%
BEAT
11/21
03:17 pm
Maintains
Buy
Buy
Citigroup
Low
-1.0%
11/21
03:17 pm
Maintains
Buy
Buy
Citigroup
Low
-1.0%
11/17
12:23 pm
Maintains
Overweight
Overweight
JP Morgan
Low
-1.5%
11/14
12:40 pm
Maintains
Buy
Buy
Canaccord Genuity
Low
-0.8%
11/13
09:52 am
Upgrades
Equal Weight
Overweight
Stephens
Medium
-7.9%
12/2
07:33 am
evh
Low
Form 8-K Evolent Health, Inc. For: Dec 01
11/19
04:23 pm
evh
Low
Form 4 Evolent Health, Inc. For: Nov 18 Filed by: Springstubb Brendan B
11/14
05:27 pm
evh
Medium
Form SCHEDULE 13G Evolent Health, Inc. Filed by: Boehler Adam
11/14
04:33 pm
evh
Medium
Form SCHEDULE 13G/A Evolent Health, Inc. Filed by: Durable Capital Partners LP
11/14
03:37 pm
evh
Low
Form SCHEDULE 13G/A Evolent Health, Inc. Filed by: EVENTIDE ASSET MANAGEMENT, LLC
Show more
Top News Gainers
3/26 Evolent Health Inc (NYSE: EVH) had its price target lowered by analysts at SunTrust Banks, Inc. from $16.00 to $12.00. They now have a "buy" rating on the stock. 31.4%
8/6 Evolent Health Announces Second Quarter 2019 Results 17.0%
11/27 Evolent Health Partner Passport Health Plan is Not Initially Selected for Kentucky Managed Medicaid Contract 15.8%
12/5 Form 4 Evolent Health, Inc. For: Dec 03 Filed by: WILLIAMS FRANK J 15.0%
11/5 Q3/2019 9/30/2019 EPS -0.090 ZacksConsensus -0.210 ActVsEst 0.120 - Beat 13.4%
4/29 Evolent Health to Participate in Upcoming Investor Conference 10.8%
1/15 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 9.5%
5/29 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. 8.3%
8/12 IMPORTANT INVESTOR REMINDER: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Evolent Health, Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm 7.0%
4/23 Evolent Health, Inc. to Release First Quarter 2020 Operating Results and Host Conference Call on Thursday, May 7, 2020 6.7%
Top News Decliners
5/29 Evolent Health Expands Partnership with Passport Health Plan to Support Medicaid Beneficiaries in the Commonwealth of Kentucky -29.3%
3/4 Evolent Health Inc (NYSE: EVH) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. -23.1%
9/11 Evolent Health Inc (NYSE: EVH) was given a new $10.00 price target on by analysts at Piper Jaffray Companies. They now have a "buy" rating on the stock. -14.5%
4/29 Form DEF 14A Evolent Health, Inc. For: Jun 09 -10.0%
12/2 Evolent Health Inc (NYSE: EVH) had its "overweight" rating re-affirmed by analysts at KeyCorp. They now have a $10.00 price target on the stock, down previously from $20.00. -8.3%
12/10 The Co-Founder of Evolent Health, Inc. (NYSE:EVH), Frank Williams, Just Bought 5.8% More Shares [Yahoo! Finance News] -7.4%
8/14 Glancy Prongay & Murray LLP Announces Investigation on Behalf of Evolent Health, Inc. Investors (EVH) -7.2%
3/12 Evolent Health Inc (NYSE: EVH) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -7.0%
8/13 EVOLENT HEALTH SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Evolent Health, Inc. - EVH -6.7%
11/27 Evolent Health Inc (NYSE: EVH) had its price target lowered by analysts at Piper Jaffray Companies to $10.15. They now have an "overweight" rating on the stock. -6.6%
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.
Click Here To Register For The Live Online Workshop
In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview
Earnings Week Wrap-up and Takeaways
Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix
Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More
The Smart Way to Ten Minutes Per Day

Information

Support

Contact us

20715 N Pima Rd #F108
Scottsdale, AZ 85255
Email: info@newsquantified.com
Copyright Ⓒ News Quanitifed LLC. 1.1.3